Aventis Pasteur filed a biologics license application for Menactra, a conjugate vaccine believed to provide protection against meningococcal meningitis for a longer period than the company's currently marketed product. (BioWorld Today)
Aventis Pasteur filed a biologics license application for Menactra, a conjugate vaccine believed to provide protection against meningococcal meningitis for a longer period than the company's currently marketed product. (BioWorld Today)